You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage III Classical Hodgkin Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Sep 19, 2023

Circulating Tumor DNA Genotyping for Biological Monitoring of

Active, not recruiting
  • Hodgkin Lymphoma
    • Avellino, Italy
    • +12 more
    Dec 22, 2022

    Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • Cologne, Germany
      University Hospital of Cologne
    Aug 5, 2022

    Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Aug 5, 2022

    Relapsed or Refractory Hodgkin Lymphoma Trial in Beijing (SHR2554+ SHR1701, SHR-1701)

    Recruiting
    • Relapsed or Refractory Hodgkin Lymphoma
    • Beijing, Beijing, China
      Han wei dong
    Jun 14, 2023

    Hodgkin Lymphoma Trial (pembrolizumab, brentuximab vedotin)

    Active, not recruiting
    • Hodgkin Lymphoma
    • pembrolizumab
    • brentuximab vedotin
    • (no location specified)
    Aug 18, 2022

    Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • GEN3017
    • (no location specified)
    Aug 25, 2023

    Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Feb 1, 2023

    Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • Alessandria, Italy
    • +45 more
    Dec 22, 2022

    Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

    Active, not recruiting
    • Classical Hodgkin Lymphoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 28, 2022

    Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Zimberelimab 240mg
    • Guangzhou, Guangdong, China
      Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
    Jun 15, 2023

    Hodgkin Lymphoma Trial in Saint Petersburg (Prolgolimab, Combination with prolgolimab and bendamustine)

    Recruiting
    • Hodgkin Lymphoma
    • Saint Petersburg, Russian Federation
    • +1 more
    Mar 3, 2023

    Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

    Active, not recruiting
    • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • External Beam Radiation Therapy
    • Orbital Radiation
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Hodgkin's Lymphoma Trial in Seattle (Pembrolizumab, Umbralisib)

    Terminated
    • Hodgkin's Lymphoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 22, 2022

    Hodgkin Lymphoma Trial in Moscow (Nivolumab)

    Recruiting
    • Hodgkin Lymphoma
    • Moscow, Russian Federation
      The Federal Budget-Funded Institution National Medical Surgical
    Oct 31, 2022

    Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

    Not yet recruiting
    • Recurrent Classic Hodgkin Lymphoma
    • Refractory Classic Hodgkin Lymphoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +13 more
    • (no location specified)
    Feb 2, 2023

    Classical Hodgkin Lymphoma Trial in Cologne (Pembrolizumab plus Chemotherapy (ICE or DHAP))

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Pembrolizumab plus Chemotherapy (ICE or DHAP)
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Aug 5, 2022

    Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

    Withdrawn
    • Hodgkin Lymphoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 28, 2022

    HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,

    Active, not recruiting
    • HIV Infection
    • +3 more
    • brentuximab vedotin
    • +3 more
    • Clamart, France
    • +5 more
    Aug 11, 2022

    Hodgkin Lymphoma Trial (favezelimab/pembrolizumab, bendamustine, gemcitabine)

    Not yet recruiting
    • Hodgkin Lymphoma
    • favezelimab/pembrolizumab
    • +2 more
    • (no location specified)
    Aug 18, 2022

    Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Charlottesville, Virginia
      University of Virginia
    Jul 27, 2022

    Advanced Classical Hodgkin's Lymphoma in Brazil Treated With

    Not yet recruiting
    • Hodgkin Lymphoma
    • No Intervention
    • Salvador, Bahia, Brazil
    • +5 more
    Oct 23, 2023

    Recurrent/Refractory Classical Hodgkin's Lymphoma Trial in Tianjin (AK105,Anrotinib HCl)

    Enrolling by invitation
    • Recurrent/Refractory Classical Hodgkin's Lymphoma
    • AK105，Anrotinib hydrochloride
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Insititute & Hospital
    Jan 12, 2023

    Allogeneic Hematopoietic Cell Transplantation For Classical

    Active, not recruiting
    • Lymphoma
    • Non-Interventional
    • Princeton, New Jersey
    • +1 more
    Mar 14, 2022

    Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 8, 2022